All In MedTech

Device Trial Radar · NCT06047964

SeQuent ® Please CIS for the Treatment of INtracranial Atherosclerotic Stenosis

A Prospective, Multicenter, Clinical Trial to Evaluate the Safety and Effectiveness of the Intracranial Paclitaxel Drug-eluting Balloon Catheters (SeQuent® Please CIS) in the Endovascular Treatment of Symptomatic Intracranial Atherosclerotic Stenosis and Restenosis After Interventional Therapy

Last checked: Nov 20, 2026Latest source record: Jun 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingRandomized with 281 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

281

Actual

Start

Mar 23, 2023

Primary completion

Sep 29, 2024

Study completion Sep 30, 2026

Sponsor

Lead sponsor
B. Braun Medical International Trading Company Ltd.Not on our public-company list
Sponsor type
Industry
First posted
Sep 21, 2023

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated device
No
Who can join
All sexes, from 18 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study is aiming to evaluate the safety and efficacy of SeQuent® Please CIS in the endovascular treatment of symptomatic intracranial atherosclerotic stenosis and restenosis after interventional therapy.

Conditions

  • Stroke
  • Intracranial Atherosclerotic Stenosis

Interventions

  • DCBDevice

    Intracranial paclitaxel drug-eluting balloon catheters (SeQuent® Please CIS)

  • POBADevice

    Intracranial PTA balloon catheter

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. restenosis incidence of target lesionTime frame: 6 months post-procedure

Locations

9 sites in 1 country. Site status is shown where the registry gives one.

  • Xuanwu Hospital, Capital Medical University

    Beijing, Beijing Municipality, China

8 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.